IMCIVREE
Live / Registered — Registered (as of 25 May 2021)
What this means for you
Registered since 25 May 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88226182
- Registration number
- 6364874
- Mark type
- Stylized text
- Filed
- 12 Dec 2018
- Published for opposition
- 14 May 2019
- Registered
- 25 May 2021
- Attorney of record
- Peter G. Byrne, Esq.
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals and medicines for the treatment of obesity and metabolic diseases and disorders
Owner
- Rhythm Pharmaceuticals, Inc., BOSTON, MA, US
- Rhythm Pharmaceuticals, Inc., BOSTON, MA, US
- Rhythm Pharmaceuticals, Inc., Boston, MA, US
Prosecution history
- 20 Jun 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 20 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Feb 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Feb 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 16 Feb 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 Feb 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 May 2021 — REGISTERED-PRINCIPAL REGISTER
- 23 Apr 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Apr 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Apr 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Mar 2021 — USE AMENDMENT FILED
- 12 Apr 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Mar 2021 — TEAS STATEMENT OF USE RECEIVED